Fesoterodine Fumarate

Alembic Pharmaceuticals Limited🇺🇸 United States

FDA Page

Effective Date: Jan 30, 2023
Approval ID: 571147f2-e182-44b5-9d0b-ecfc3265cc2d
Products: 2 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use FESOTERODINE FUMARATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for FESOTERODINE FUMARATE EXTENDED-RELEASE TABLETS. FESOTERODINE FUMARATE extended-release tablets, for oral use Initial U.S. Approval: 2008

Quick Stats

Total Products2

Labelers2

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.